» Articles » PMID: 9081618

Erythropoietin Gene Expression in Human, Monkey and Murine Brain

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 1996 Apr 1
PMID 9081618
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

The haematopoietic growth factor erythropoietin is the primary regulator of mammalian erythropoiesis and is produced by the kidney and the liver in an oxygen-dependent manner. We and others have recently demonstrated erythropoietin gene expression in the rodent brain. In this work, we show that cerebral erythropoietin gene expression is not restricted to rodents but occurs also in the primate brain. Erythropoietin mRNA was detected in biopsies from the human hippocampus, amygdala and temporal cortex and in various brain areas of the monkey Macaca mulatta. Exposure to a low level of oxygen led to elevated erythropoietin mRNA levels in the monkey brain, as did anaemia in the mouse brain. In addition, erythropoietin receptor mRNA was detected in all brain biopsies tested from man, monkey and mouse. Analysis of primary cerebral cells isolated from newborn mice revealed that astrocytes, but not microglia cells, expressed erythropoietin. When incubated at 1% oxygen, astrocytes showed >100-fold time-dependent erythropoietin mRNA accumulation, as measured with the quantitative reverse transcription-polymerase chain reaction. The specificity of hypoxic gene induction in these cells was confirmed by quantitative Northern blot analysis showing hypoxic up-regulation of mRNA encoding the vascular endothelial growth factor, but not of other genes. These findings demonstrate that erythropoietin and its receptor are expressed in the brain of primates as they are in rodents, and that, at least in mice, primary astrocytes are a source of cerebral erythropoietin expression which can be up-regulated by reduced oxygenation.

Citing Articles

EPO Deficiency Upregulates GADD45b/p38 MAPK Axis, Mediating Schizophrenia-Related Synaptic and Cognitive Impairments.

Guo C, Li W, Liu Y, Tao X, Mahaman Y, Wang J Adv Sci (Weinh). 2024; 11(47):e2406979.

PMID: 39467064 PMC: 11653605. DOI: 10.1002/advs.202406979.


Erythropoietin restrains the inhibitory potential of interneurons in the mouse hippocampus.

Curto Y, Carceller H, Klimczak P, Perez-Rando M, Wang Q, Grewe K Mol Psychiatry. 2024; 29(10):2979-2996.

PMID: 38622200 PMC: 11449791. DOI: 10.1038/s41380-024-02528-2.


Recombinant human erythropoietin protects against immature brain damage induced by hypoxic/ischemia insult.

Sun Z, Song J, Song Q, Li L, Tian X, Wang L Neuroreport. 2023; 34(17):801-810.

PMID: 37938927 PMC: 10609708. DOI: 10.1097/WNR.0000000000001957.


Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress.

Ehrenreich H, Gassmann M, Poustka L, Burtscher M, Hammermann P, Siren A Neuroprotection. 2023; 1(1):9-19.

PMID: 37671067 PMC: 7615021. DOI: 10.1002/nep3.15.


Tectorigenin: A Review of Its Sources, Pharmacology, Toxicity, and Pharmacokinetics.

Rong J, Fu F, Han C, Wu Y, Xia Q, Du D Molecules. 2023; 28(15).

PMID: 37570873 PMC: 10421414. DOI: 10.3390/molecules28155904.